Cargando…

The Endocannabinoid System and Oligodendrocytes in Health and Disease

Cannabinoid-based interventions are being explored for central nervous system (CNS) pathologies such as neurodegeneration, demyelination, epilepsy, stroke, and trauma. As these disease states involve dysregulation of myelin integrity and/or remyelination, it is important to consider effects of the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilyasov, Alexander A., Milligan, Carolanne E., Pharr, Emily P., Howlett, Allyn C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214135/
https://www.ncbi.nlm.nih.gov/pubmed/30416422
http://dx.doi.org/10.3389/fnins.2018.00733
_version_ 1783367932563161088
author Ilyasov, Alexander A.
Milligan, Carolanne E.
Pharr, Emily P.
Howlett, Allyn C.
author_facet Ilyasov, Alexander A.
Milligan, Carolanne E.
Pharr, Emily P.
Howlett, Allyn C.
author_sort Ilyasov, Alexander A.
collection PubMed
description Cannabinoid-based interventions are being explored for central nervous system (CNS) pathologies such as neurodegeneration, demyelination, epilepsy, stroke, and trauma. As these disease states involve dysregulation of myelin integrity and/or remyelination, it is important to consider effects of the endocannabinoid system on oligodendrocytes and their precursors. In this review, we examine research reports on the effects of the endocannabinoid system (ECS) components on oligodendrocytes and their precursors, with a focus on therapeutic implications. Cannabinoid ligands and modulators of the endocannabinoid system promote cell signaling in oligodendrocyte precursor survival, proliferation, migration and differentiation, and mature oligodendrocyte survival and myelination. Agonist stimulation of oligodendrocyte precursor cells (OPCs) at both CB(1) and CB(2) receptors counter apoptotic processes via Akt/PI3K, and promote proliferation via Akt/mTOR and ERK pathways. CB(1) receptors in radial glia promote proliferation and conversion to progenitors fated to become oligodendroglia, whereas CB(2) receptors promote OPC migration in neonatal development. OPCs produce 2-arachidonoylglycerol (2-AG), stimulating cannabinoid receptor-mediated ERK pathways responsible for differentiation to arborized, myelin basic protein (MBP)-producing oligodendrocytes. In cell culture models of excitotoxicity, increased reactive oxygen species, and depolarization-dependent calcium influx, CB(1) agonists improved viability of oligodendrocytes. In transient and permanent middle cerebral artery occlusion models of anoxic stroke, WIN55212-2 increased OPC proliferation and maturation to oligodendroglia, thereby reducing cerebral tissue damage. In several models of rodent encephalomyelitis, chronic treatment with cannabinoid agonists ameliorated the damage by promoting OPC survival and oligodendrocyte function. Pharmacotherapeutic strategies based upon ECS and oligodendrocyte production and survival should be considered.
format Online
Article
Text
id pubmed-6214135
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62141352018-11-09 The Endocannabinoid System and Oligodendrocytes in Health and Disease Ilyasov, Alexander A. Milligan, Carolanne E. Pharr, Emily P. Howlett, Allyn C. Front Neurosci Neuroscience Cannabinoid-based interventions are being explored for central nervous system (CNS) pathologies such as neurodegeneration, demyelination, epilepsy, stroke, and trauma. As these disease states involve dysregulation of myelin integrity and/or remyelination, it is important to consider effects of the endocannabinoid system on oligodendrocytes and their precursors. In this review, we examine research reports on the effects of the endocannabinoid system (ECS) components on oligodendrocytes and their precursors, with a focus on therapeutic implications. Cannabinoid ligands and modulators of the endocannabinoid system promote cell signaling in oligodendrocyte precursor survival, proliferation, migration and differentiation, and mature oligodendrocyte survival and myelination. Agonist stimulation of oligodendrocyte precursor cells (OPCs) at both CB(1) and CB(2) receptors counter apoptotic processes via Akt/PI3K, and promote proliferation via Akt/mTOR and ERK pathways. CB(1) receptors in radial glia promote proliferation and conversion to progenitors fated to become oligodendroglia, whereas CB(2) receptors promote OPC migration in neonatal development. OPCs produce 2-arachidonoylglycerol (2-AG), stimulating cannabinoid receptor-mediated ERK pathways responsible for differentiation to arborized, myelin basic protein (MBP)-producing oligodendrocytes. In cell culture models of excitotoxicity, increased reactive oxygen species, and depolarization-dependent calcium influx, CB(1) agonists improved viability of oligodendrocytes. In transient and permanent middle cerebral artery occlusion models of anoxic stroke, WIN55212-2 increased OPC proliferation and maturation to oligodendroglia, thereby reducing cerebral tissue damage. In several models of rodent encephalomyelitis, chronic treatment with cannabinoid agonists ameliorated the damage by promoting OPC survival and oligodendrocyte function. Pharmacotherapeutic strategies based upon ECS and oligodendrocyte production and survival should be considered. Frontiers Media S.A. 2018-10-26 /pmc/articles/PMC6214135/ /pubmed/30416422 http://dx.doi.org/10.3389/fnins.2018.00733 Text en Copyright © 2018 Ilyasov, Milligan, Pharr and Howlett. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Ilyasov, Alexander A.
Milligan, Carolanne E.
Pharr, Emily P.
Howlett, Allyn C.
The Endocannabinoid System and Oligodendrocytes in Health and Disease
title The Endocannabinoid System and Oligodendrocytes in Health and Disease
title_full The Endocannabinoid System and Oligodendrocytes in Health and Disease
title_fullStr The Endocannabinoid System and Oligodendrocytes in Health and Disease
title_full_unstemmed The Endocannabinoid System and Oligodendrocytes in Health and Disease
title_short The Endocannabinoid System and Oligodendrocytes in Health and Disease
title_sort endocannabinoid system and oligodendrocytes in health and disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214135/
https://www.ncbi.nlm.nih.gov/pubmed/30416422
http://dx.doi.org/10.3389/fnins.2018.00733
work_keys_str_mv AT ilyasovalexandera theendocannabinoidsystemandoligodendrocytesinhealthanddisease
AT milligancarolannee theendocannabinoidsystemandoligodendrocytesinhealthanddisease
AT pharremilyp theendocannabinoidsystemandoligodendrocytesinhealthanddisease
AT howlettallync theendocannabinoidsystemandoligodendrocytesinhealthanddisease
AT ilyasovalexandera endocannabinoidsystemandoligodendrocytesinhealthanddisease
AT milligancarolannee endocannabinoidsystemandoligodendrocytesinhealthanddisease
AT pharremilyp endocannabinoidsystemandoligodendrocytesinhealthanddisease
AT howlettallync endocannabinoidsystemandoligodendrocytesinhealthanddisease